At Echometrix, our patented, breakthrough, ultrasound-based products will be used to provide an objective, quantitative initial diagnosis and to objectively measure patient outcomes during rehabilitation. These advancements can potentially help decrease missed work days for injured workers, improve athlete performance and measure the efficacy of new therapies.
More than 1 in 4 Americans has a musculoskeletal condition requiring medical attention. Approximately 28% of these conditions were the result of musculoskeletal injuries. Out of a total of more than 24 million total injuries annually, 18.4 million sprain and strain injuries are recorded. Our products will provide ongoing measurement of tissue rehabilitation, optimizing physical therapy for workers, soldiers and athletes.
Sprain and strain injuries cost U.S. healthcare payers $92 billion annually. Use of MRI for the routine diagnosis of musculoskeletal conditions will create a $2.5 billion cost problem in the U.S. by 2020, which could be avoided by increasing the use of ultrasound. Echometrix's advanced ultrasound will help to significantly decrease medical imaging costs.